These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29484414)

  • 1. Raf1 is a prognostic factor for progression in patients with non‑small cell lung cancer after radiotherapy.
    Tian H; Yin L; Ding K; Xia YY; Wang XH; Wu JZ; He X
    Oncol Rep; 2018 Apr; 39(4):1966-1974. PubMed ID: 29484414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TAZ is an independent prognostic factor in non-small cell lung carcinoma: Elucidation at protein level.
    Malik SA; Khan MS; Dar M; Hussain MU; Mudassar S
    Cancer Biomark; 2017; 18(4):389-395. PubMed ID: 28128737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
    Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
    BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
    Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
    Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
    Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS
    Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A three gene-based risk score predicts prognosis of resected non-small-cell lung cancer.
    Liu K; Chen HL; Gu MM; You QS
    Int J Clin Exp Pathol; 2015; 8(12):16081-8. PubMed ID: 26884885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
    Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
    Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LATS2 as a poor prognostic marker regulates non-small cell lung cancer invasion by modulating MMPs expression.
    Wu A; Li J; Wu K; Mo Y; Luo Y; Ye H; Mai Z; Guo K; Wang Y; Li S; Chen H; Luo W; Yang Z
    Biomed Pharmacother; 2016 Aug; 82():290-7. PubMed ID: 27470365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
    Yang H; Gao XY; Li P; Jiang TS
    Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HBXIP suppression reduces cell proliferation and migration and its overexpression predicts poor prognosis in non-small-cell lung cancer.
    Wang Y; Li N; Che S; Jin T; Piao J; Liu S; Lin Z
    Tumour Biol; 2017 Jul; 39(7):1010428317709675. PubMed ID: 28718367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpressed C14orf166 associates with disease progression and poor prognosis in non-small-cell lung cancer.
    Zhou YW; Li R; Duan CJ; Gao Y; Cheng YD; Zhang CF
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30126850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of high expression levels of STK39 in the growth, migration and invasion of non-small cell type lung cancer cells.
    Li Z; Zhu W; Xiong L; Yu X; Chen X; Lin Q
    Oncotarget; 2016 Sep; 7(38):61366-61377. PubMed ID: 27542260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulated microRNA-375 expression as a predictive biomarker in non-small cell lung cancer brain metastasis and its prognostic significance.
    Chen LJ; Li XY; Zhao YQ; Liu WJ; Wu HJ; Liu J; Mu XQ; Wu HB
    Pathol Res Pract; 2017 Aug; 213(8):882-888. PubMed ID: 28688608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer.
    Kong F; Gao F; Chen J; Sun Y; Zhang Y; Liu H; Li X; Yang P; Zheng R; Liu G; Jia Y
    Oncotarget; 2016 Aug; 7(35):56193-56199. PubMed ID: 27486880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of DEK overexpression for the prognostic evaluation of non-small cell lung carcinoma.
    Liu X; Qi D; Qi J; Mao Z; Li X; Zhang J; Li J; Gao W
    Oncol Rep; 2016 Jan; 35(1):155-62. PubMed ID: 26530274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA ROR is a novel prognosis factor associated with non-small-cell lung cancer progression.
    Qu CH; Sun QY; Zhang FM; Jia YM
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4087-4091. PubMed ID: 29028092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
    Yang J; Liu H; Wang H; Sun Y
    Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Significance and Tumor-Suppressive Function of miR-516b in Nonsmall Cell Lung Cancer.
    Zhu J; Zhang Y; Yang X; Jin L
    Cancer Biother Radiopharm; 2017 May; 32(4):115-123. PubMed ID: 28514208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
    Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of miR-503 expression predicate advanced mythological features and poor prognosis in patients with NSCLC.
    Liu L; Qu W; Zhong Z
    Int J Clin Exp Pathol; 2015; 8(5):5609-13. PubMed ID: 26191272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.